Key result
Long-term treatment with low-dose G-CSF significantly mitigated cardiac remodelling and dysfunction in post-MI mice, possibly through STAT3-mediated mechanisms.
Why the study?
Does long-term, low-dose G-CSF improve cardiac remodelling and dysfunction in a mouse model of myocardial infarction?
Does long-term, low-dose G-CSF improve cardiac remodelling and dysfunction in a mouse model of myocardial infarction?
Long-term, low-dose G-CSF mitigates post-infarction cardiac remodelling and dysfunction in mice, primarily through STAT3-mediated pathways.
No takes yet. Share an insight, caveat, or question.
Does not support clinical use; extends animal RCT evidence while leaving human translation open.
Okada et al. (2008) studied myocardial infarction. granulocyte colony-stimulating factor (G-CSF) was evaluated on cardiac remodelling and dysfunction. Long-term treatment with low-dose G-CSF significantly mitigated cardiac remodelling and dysfunction in post-MI mice, possibly through STAT3-mediated mechanisms.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: